A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma
- 1 June 1996
- journal article
- clinical trial
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 10 (2) , 193-200
- https://doi.org/10.1007/bf03165392
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Diagnostic Efficacy of PET-FDG Imaging in Solitary Pulmonary NodulesChest, 1993
- Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Laser Projection System for Radiotherapy and CT-Guided BiopsyJournal of Computer Assisted Tomography, 1990
- Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-d-glucose and positron emission tomography: Preliminary study of lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1990
- High [18F]-Fluorodeoxyglucose Uptake in Abdominal AbscessesJournal of Computer Assisted Tomography, 1989
- Recurrence of colorectal tumors: PET evaluation.Radiology, 1989
- Positron emission tomography in patients with glioma a predictor of prognosisCancer, 1988
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1986